CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses

针对SARS-CoV-2核衣壳免疫优势表位的CD8+ T细胞与某些季节性冠状病毒发生交叉反应

阅读:3
作者:Katie E Lineburg,Emma J Grant,Srividhya Swaminathan,Demetra S M Chatzileontiadou,Christopher Szeto,Hannah Sloane,Archana Panikkar,Jyothy Raju,Pauline Crooks,Sweera Rehan,Andrea T Nguyen,Lea Lekieffre,Michelle A Neller,Zhen Wei Marcus Tong,Dhilshan Jayasinghe,Keng Yih Chew,Christian A Lobos,Hanim Halim,Jacqueline M Burrows,Alan Riboldi-Tunnicliffe,Weisan Chen,Lloyd D'Orsogna,Rajiv Khanna,Kirsty R Short,Corey Smith,Stephanie Gras

Abstract

Efforts are being made worldwide to understand the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, including the impact of T cell immunity and cross-recognition with seasonal coronaviruses. Screening of SARS-CoV-2 peptide pools revealed that the nucleocapsid (N) protein induced an immunodominant response in HLA-B7+ COVID-19-recovered individuals that was also detectable in unexposed donors. A single N-encoded epitope that was highly conserved across circulating coronaviruses drove this immunodominant response. In vitro peptide stimulation and crystal structure analyses revealed T cell-mediated cross-reactivity toward circulating OC43 and HKU-1 betacoronaviruses but not 229E or NL63 alphacoronaviruses because of different peptide conformations. T cell receptor (TCR) sequencing indicated that cross-reactivity was driven by private TCR repertoires with a bias for TRBV27 and a long CDR3β loop. Our findings demonstrate the basis of selective T cell cross-reactivity for an immunodominant SARS-CoV-2 epitope and its homologs from seasonal coronaviruses, suggesting long-lasting protective immunity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。